Stocks · Health care · Pharmaceutical Preparations

Annexon, Inc.

ANNX Clue Score37
United States Fiscal year ends December CIK 0001528115 Results filed 12 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Ted Yednock
19 Sep 2024
EVP & Chief Innovation Officer
Sold on a plan indirect
4,500
$7.10
$31.95K
Ted Yednock
12 Sep 2024
EVP & Chief Innovation Officer
Sold on a plan indirect
5,500
$6.16
$33.88K
Ted Yednock
5 Sep 2024
EVP & Chief Innovation Officer
Sold on a plan indirect
5,500
$5.64
$31.02K
Ted Yednock
29 Aug 2024
EVP & Chief Innovation Officer
Sold on a plan indirect
5,500
$5.95
$32.73K

What was left out

Form 4 filings counted 172
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 25
Sales at will 39
Transactions with no price 0
Shares from compensation/vesting 10,927,333
Sales filed before the plan box existed 5
History held since 24 Jul 2020